• Home
  • About
    • Group CEO
    • Management Team
    • Supervisory Board
    • Scientific Advisory Board
    • Affiliates
    • R&D Partnerships
    • Distributors
    • Quality Standards
    • Location
  • Services
    • Proteomics
    • Genomics Transcriptomics
    • Flow Cytometry
    • Assay Development
    • Monoclonal Antibodies
    • Biobanking
    • OLINK Services
    • Biomarker Data Analyses
  • R&D
  • Products
    • NEUROLINCS
    • FIMICS
    • BIOPRED
    • IVD Products
    • ELISA Kits
    • Recombinant Proteins
    • Monoclonal Abodies
    • Clinical Samples
    • Your Customized Kit
  • Quality
  • Investors
    • Financial Management
    • Financial Data
    • Shareholders
  • Media
    • Press Releases
    • Media News
    • Newsletters
    • Posts
    • All Media
  • Careers
Contact
Firalis
  • Home
  • About
  • Services
  • Products
  • R&D
  • Quality
  • Investors
  • Media
2004302651442-huseyin-firat-pdg-ceo-firalis.jpg

FIRALIS GROUP CEO

Hüseyin FIRAT, MD, PhD
CSO-CEO of Firalis Group

 

Prof. Hüseyin FIRAT is a pediatrician and practiced as an associate professor in Paris University Hospitals. Following his PhD of Immunology at Pasteur Institute, he was accredited as research director, responsible of the Immunology Laboratory at Généthon.

 

In 2002, he joined the Biomarker Department of Novartis Pharma, where he headed global omics data analysis sections, served as senior Biomarker Expert in International Project Teams and was a member of Novartis Pharma Innovation Team in Basel. His research activities generated several patented discoveries, based on which three biotech companies have been created.

 

In 2007, he has been accredited as University Professor in France and founded Firalis in 2008. Since then, he is the CEO and President of Firalis and of its affiliates acquired or created since mid-2013. Via Firalis and its affiliates, Prof. Firat initiated and coordinated numerous European consortia on clinical biomarker qualification such as SAFE-T, CARDIO-SAVE, MIPROG, ADDIA, RABIOPRED and HEARTLINC.

 

He is Author of > 70 Publications.

Contact Firalis

Firalis Group

© Copyright 2020 all rights reserved. 

The company logos, products and service marks are trademarks or registered trademarks of Firalis.

-----------------------------------------------------------------------------------------------------------------------

Information addressed to health professionals. The products presented on this site are for professional use only and, where applicable, comply with the requirements of the IVD Directive 98/79 / EC. Instructions for use must be consulted before using these products.

-----------------------------------------------------------------------------------------------------------------------

Headquarter : 17 Rue du Fort 68330 Huningue FRANCE